Category

Clinical Trials

Bavarian Nordic

Bavarian Nordic initiates Phase 2 trial

July 24, 2018

The first patient has been …

A1M Pharma

Positive results from A1M Pharma

July 24, 2018

The company has reported positive …

jakob_lindberg_oncopeptides

Oncopeptide update clinical trial

June 27, 2018

Oncopeptides present updated interim data …

mene_p_astrazeneca

AstraZeneca discontinues Alzheimer trials

June 25, 2018

AstraZeneca and Eli Lilly and …

Jan Alenfall

Follicum’s hair growth study fully recruited

June 19, 2018

Follicum announces that all patients …

Lundbeck Research

Positive results from Lundbeck trial

June 15, 2018

H. Lundbeck A/S and Takeda …

lundbeck-research

Positive EU opinion for Lundbeck

June 7, 2018

Lundbeck and Otsuka Pharmaceutical announce …

Novo Nordisk headquarters

Headline results from Novo Nordisk’s Pioneer trial

June 7, 2018

The company has anounced results …

AstraZeneca Research and Development

AstraZeneca and MSD present new results about Lynparza

June 7, 2018

The two pharma giants reports …

Nordic Nanovector

Nordic Nanovector’s Paradigme trial approved to start

May 30, 2018

The Phase 2b trial with …

astrazeneca rd

AstraZeneca’s TERRANOVA trial has not met the primary endpoint

May 30, 2018

The trial, the second of …

Adam Steensberg

Zealand Pharma completes Phase 3 trial with dasiglucagon

May 29, 2018

All subjects have been enrolled …

Signing papers

Nordic Nanovector update clinical trial application

May 28, 2018

The company has received feedback …

laboratory-technician-protein-separation_genmab

Janssen will stop studies on daratumumab in combination with Anti-PD-(L)1

May 28, 2018

Following a planned review, the …

Jan van de Winkel

Disappointing results from Genmab’s Arzerra study

May 25, 2018

The results from the Phase …

AstraZeneca research

New results from AstraZeneca’s PACIFIC trial

May 25, 2018

AstraZeneca and MedImmune has announced …

1
2
3
4
···
20